
Keeping an Eye on Lyell Immunopharma Inc (LYEL) After Insider Trading Activity
Lyell Immunopharma Inc’s recently made public that its Director BRAWLEY OTIS W acquired Company’s shares for reported $19958.0 on Mar
Lyell Immunopharma Inc’s recently made public that its Director BRAWLEY OTIS W acquired Company’s shares for reported $19958.0 on Mar
ONE Group Hospitality Inc’s recent filing unveils that its CHIEF FINANCIAL OFFICER Loy Tyler acquired Company’s shares for reported $25500.0
Olema Pharmaceuticals Inc’s recent filing unveils that its 10% Owner Bain Capital Life Sciences Inv acquired Company’s shares for reported
In a filing, Cincinnati Financial Corp revealed its Director Benacci Nancy Cunningham acquired Company’s shares for reported $0.14 million on
Sunopta, Inc’s recently made public that its CEO Kocher Brian W acquired Company’s shares for reported $57194.0 on Jun 10
In a filing, Teads Holding Co revealed its Chief Executive Officer Kostman David acquired Company’s shares for reported $79600.0 on
Wynn Resorts Ltd’s filing revealed that its Director Mulroy Patricia unloaded Company’s shares for reported $0.21 million on May 29
Galectin Therapeutics Inc’s recently made public that its Director Shlevin Harold H. acquired Company’s shares for reported $7540.0 on Dec
Oruka Therapeutics Inc’s recent filing unveils that its 10% Owner Venrock Healthcare Capital Par acquired Company’s shares for reported $1.02
Eagle Financial Services, Inc’s filing revealed that its Director HILL EDWARD III acquired Company’s shares for reported $29932.0 on Jun